View Author

Bout, A.

( A. Bout)


vector tumor ig.ad luciferase e 3tk adenoviral ig.ad 5e adenoviral vectors expression cancer perfusion virus administration limb perfusion therapy replication-competent ig.ad 5e intratumoral tissue intratumoral injection glioma injection transfer m.o.i luciferase activity infection adenoviru replication promoter study cell lines activity e 3 promoter animal ig.adapt.tk effect tumor growth delivery hsv 1-tk treatment region tumor tissue sequence glioma cell lines hsv 1-tk gene e 3 region organ brain tumors tumor cells oncolytic effect netherland e 1 region growth 87 mg cells e 3luc gene transfer brain gene therapy efficacy luciferase expression result factor replication-competent adenoviral vectors nonreplicating tumor necrosis factor wtad 5 control expression levels addition level hum gene minute protein circuit rotterdam luciferase gene expression luciferase marker gene e 1 vector sarcoma oncolytic adenovirus-mediated gene transfer




2 Most Recent Publications

Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase (Article)
Nanda, D. Vogels, R. Havenga, M. Avezaat, C.J.J. Bout, A. Smitt, P.S.
2001-01-01
Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas (Article)
Roos, W.K. de Wilt, J.H.W. de Kaaden, M.E. van der Manusama, E.R. Vries, M.W. de Bout, A. Hagen, T.L.M. ten Valerio, D. Eggermont, A.M.M.
2000-01-01